What is Inovio Pharmaceuticals, Inc.'s Market Cap?

Inovio Pharmaceuticals, Inc.'s Market Cap is $146.8M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Enterprise Value?

Inovio Pharmaceuticals, Inc.'s Enterprise Value is $110.2M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s EV / EBITDA?

Inovio Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Revenue (TTM)?

Inovio Pharmaceuticals, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Net Income (TTM)?

Inovio Pharmaceuticals, Inc.'s Net Income (TTM) is -$67.4M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s EBITDA?

Inovio Pharmaceuticals, Inc.'s EBITDA is -$77.9M, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -0.65, based on as-reported figures from SEC (XBRL) filings.

What is Inovio Pharmaceuticals, Inc.'s Net Debt?

Inovio Pharmaceuticals, Inc.'s Net Debt is -$36.7M, based on as-reported figures from SEC (XBRL) filings.

Inovio Pharmaceuticals, Inc. (INO) Financial Statements

Inovio Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S5RHZ0

XNAS · usd

1.42▼ 0.01 (-0.70%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.43

Day's Range1.38 – 1.45

52-Week Range0.56 – 2.98

Volume3.5M

Avg Volume5.6M

Share Statistics

Shares Outstanding

Employees112

ExchangeXNAS

Listed1998-12-08

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Inovio Pharmaceuticals, Inc. (INO)

What is Inovio Pharmaceuticals, Inc.'s Market Cap?: Inovio Pharmaceuticals, Inc.'s Market Cap is $146.8M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Enterprise Value?: Inovio Pharmaceuticals, Inc.'s Enterprise Value is $110.2M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s EV / EBITDA?: Inovio Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Revenue (TTM)?: Inovio Pharmaceuticals, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Net Income (TTM)?: Inovio Pharmaceuticals, Inc.'s Net Income (TTM) is -$67.4M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s EBITDA?: Inovio Pharmaceuticals, Inc.'s EBITDA is -$77.9M, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Inovio Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -0.65, based on as-reported figures from SEC (XBRL) filings.
What is Inovio Pharmaceuticals, Inc.'s Net Debt?: Inovio Pharmaceuticals, Inc.'s Net Debt is -$36.7M, based on as-reported figures from SEC (XBRL) filings.